Telomir Pharmaceuticals, Inc. (NASDAQ: TELO)
$4.2800
-0.0200 ( 0% ) 103.4K
Telomir Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical company focused on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells.
Market Data
Open
$4.2800
Previous close
$4.3000
Volume
103.4K
Market cap
$131.51M
Day range
$4.1000 - $4.4550
52 week range
$3.1100 - $20.7200
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 3 | Insider transactions | 1 | Aug 15, 2024 |
| 10-q | Quarterly Reports | 42 | Aug 13, 2024 |
| 8-k | 8K-related | 15 | Jun 24, 2024 |
| 10-q | Quarterly Reports | 42 | May 13, 2024 |
| 8-k | 8K-related | 45 | Apr 15, 2024 |
| 8-k | 8K-related | 13 | Apr 12, 2024 |
| 10-k | Annual reports | 53 | Mar 29, 2024 |
| 4 | Insider transactions | 1 | Feb 15, 2024 |
| 8-k | 8K-related | 18 | Feb 13, 2024 |
| 3 | Insider transactions | 2 | Feb 08, 2024 |